Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-01 Sale |
2021-03-01 8:08 pm |
HALOZYME THERAPEUTICS INC. | HALO | Kelley Kenneth J Director |
5,000 | $45.34 | $226,717 | 184,833 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-01 8:06 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
18,324 | $45.81 | $839,364 | 122,800 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-01 8:03 pm |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
50,000 | $46.19 | $2,309,454 | 1,087,160 (Direct) |
View |
| 2021-02-01 Sale |
2021-02-01 6:56 pm |
HALOZYME THERAPEUTICS INC. | HALO | Kelley Kenneth J Director |
5,000 | $48.12 | $240,594 | 189,833 (Direct) |
View |
| 2021-02-01 Sale |
2021-02-01 6:55 pm |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
50,000 | $47.84 | $2,391,918 | 1,070,522 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-04 5:07 pm |
HALOZYME THERAPEUTICS INC. | HALO | Kelley Kenneth J Director |
5,000 | $42.91 | $214,556 | 194,833 (Direct) |
View |
| 2020-12-21 Sale |
2020-12-21 6:01 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
12,000 | $42.58 | $510,919 | 122,800 (Direct) |
View |
| 2020-12-07 Sale |
2020-12-07 6:05 pm |
HALOZYME THERAPEUTICS INC. | HALO | Kelley Kenneth J Director |
35,086 | $41 | $1,438,526 | 199,833 (Direct) |
View |
| 2020-12-02 Sale |
2020-12-02 5:55 pm |
HALOZYME THERAPEUTICS INC. | HALO | Kelley Kenneth J Director |
31,792 | $41 | $1,303,472 | 234,919 (Direct) |
View |
| 2020-11-25 Sale |
2020-11-27 5:43 pm |
HALOZYME THERAPEUTICS INC. | HALO | Kelley Kenneth J Director |
19,671 | $41.37 | $813,850 | 266,711 (Direct) |
View |
| 2020-11-25 Sale |
2020-11-25 6:59 pm |
HALOZYME THERAPEUTICS INC. | HALO | Henderson Jeffrey William Director |
24,498 | $40.08 | $981,757 | 47,609 (Direct) |
View |
| 2020-11-25 Sale |
2020-11-25 6:57 pm |
HALOZYME THERAPEUTICS INC. | HALO | Daly James M Director |
10,363 | $40.41 | $418,800 | 21,002 (Direct) |
View |
| 2020-11-25 Sale |
2020-11-25 6:56 pm |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
50,000 | $40.73 | $2,036,568 | 1,130,522 (Direct) |
View |
| 2020-11-20 Sale |
2020-11-20 6:25 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
12,000 | $38.76 | $465,176 | 134,800 (Direct) |
View |
| 2020-10-20 Sale |
2020-10-20 4:53 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
12,000 | $30.43 | $365,148 | 146,800 (Direct) |
View |
| 2020-09-21 Sale |
2020-09-21 7:30 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
12,000 | $26.91 | $322,884 | 158,800 (Direct) |
View |
| 2020-09-11 Sale |
2020-09-14 5:33 pm |
HALOZYME THERAPEUTICS INC. | HALO | MATSUI CONNIE Director |
32,000 | $27.06 | $865,792 | 208,753 (Direct) |
View |
| 2020-08-20 Sale |
2020-08-20 4:21 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
12,000 | $28.3 | $339,564 | 170,800 (Direct) |
View |
| 2020-08-13 Sale |
2020-08-13 6:43 pm |
HALOZYME THERAPEUTICS INC. | HALO | Daly James M Director |
34,337 | $29.12 | $999,893 | 31,365 (Direct) |
View |
| 2020-07-20 Sale |
2020-07-20 6:33 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
12,000 | $29.01 | $348,072 | 182,800 (Direct) |
View |
| 2020-05-20 Sale |
2020-05-21 4:11 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
21,387 | $23.8 | $509,075 | 194,800 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-03-01 Exercise |
2021-03-01 8:03 pm |
N/A 2024-01-06 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
50,000 | $14.66 | 1,087,160 (Direct) |
View |
| 2021-02-22 Exercise |
2021-02-22 6:28 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
8,803 | $0 | 141,124 (Direct) |
View |
| 2021-02-22 Tax Withholding |
2021-02-22 6:28 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
4,364 | $48.69 | 141,124 (Direct) |
View |
| 2021-02-22 Exercise |
2021-02-22 6:27 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
39,354 | $0 | 537,160 (Direct) |
View |
| 2021-02-22 Tax Withholding |
2021-02-22 6:27 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
19,511 | $48.69 | 537,160 (Direct) |
View |
| 2021-02-15 Option Award |
2021-02-17 5:05 pm |
2022-02-15 2031-02-15 |
HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel |
36,855 | $0 | 36,855 (Direct) |
View |
| 2021-02-15 Option Award |
2021-02-17 5:04 pm |
2022-02-15 2031-02-15 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
36,855 | $0 | 36,855 (Direct) |
View |
| 2021-02-15 Option Award |
2021-02-17 5:03 pm |
2022-02-15 2031-02-15 |
HALOZYME THERAPEUTICS INC. | HALO | Sun Elaine D SVP, Chief Financial Officer |
40,540 | $0 | 40,540 (Direct) |
View |
| 2021-02-15 Option Award |
2021-02-17 5:02 pm |
2022-02-15 2031-02-15 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
142,502 | $0 | 142,502 (Direct) |
View |
| 2021-02-14 Exercise |
2021-02-16 4:56 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
5,771 | $0 | 142,456 (Direct) |
View |
| 2021-02-14 Tax Withholding |
2021-02-16 4:56 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
2,272 | $49.84 | 142,456 (Direct) |
View |
| 2021-02-14 Exercise |
2021-02-16 4:52 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
28,729 | $0 | 546,046 (Direct) |
View |
| 2021-02-14 Tax Withholding |
2021-02-16 4:52 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
14,243 | $49.84 | 546,046 (Direct) |
View |
| 2021-02-10 Tax Withholding |
2021-02-12 7:10 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel |
3,203 | $50.6 | 43,605 (Direct) |
View |
| 2021-02-10 Exercise |
2021-02-12 7:10 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel |
10,386 | $0 | 43,605 (Direct) |
View |
| 2021-02-12 Tax Withholding |
2021-02-12 7:10 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel |
2,047 | $49.84 | 43,605 (Direct) |
View |
| 2021-02-10 Tax Withholding |
2021-02-12 7:07 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
2,906 | $50.6 | 173,351 (Direct) |
View |
| 2021-02-10 Exercise |
2021-02-12 7:07 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
16,017 | $0 | 173,351 (Direct) |
View |
| 2021-02-12 Tax Withholding |
2021-02-12 7:07 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
2,725 | $49.84 | 173,351 (Direct) |
View |
| 2021-02-10 Tax Withholding |
2021-02-12 7:06 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
15,509 | $50.6 | 662,264 (Direct) |
View |
| 2021-02-10 Exercise |
2021-02-12 7:06 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
64,077 | $0 | 662,264 (Direct) |
View |
| 2021-02-12 Tax Withholding |
2021-02-12 7:06 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
16,259 | $49.84 | 662,264 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-01 6:55 pm |
N/A 2024-01-06 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
50,000 | $14.66 | 1,070,522 (Direct) |
View |
| 2020-11-30 Gift |
2020-11-30 7:57 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
10,000 | $0 | 470,522 (Direct) |
View |
| 2020-11-25 Exercise |
2020-11-25 6:56 pm |
N/A 2024-01-06 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
50,000 | $14.66 | 1,130,522 (Direct) |
View |
| 2020-09-14 Gift |
2020-09-14 5:33 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | MATSUI CONNIE Director |
8,000 | $0 | 208,753 (Direct) |
View |
| 2020-09-04 Exercise |
2020-09-04 6:13 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel |
6,884 | $0 | 25,208 (Direct) |
View |
| 2020-09-04 Tax Withholding |
2020-09-04 6:13 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Matsuda Masaru SVP, General Counsel |
2,380 | $27.7 | 25,208 (Direct) |
View |
| 2020-08-14 Gift |
2020-08-14 4:08 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen President and CEO |
10,000 | $0 | 480,522 (Direct) |
View |
| 2020-05-22 Exercise |
2020-05-22 6:39 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
18,613 | $7.14 | 194,800 (Direct) |
View |
| 2020-05-22 Exercise |
2020-05-22 6:39 pm |
N/A 2021-02-03 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
18,613 | $0 | 194,800 (Direct) |
View |
| 2020-05-20 Exercise |
2020-05-21 4:11 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
21,387 | $7.14 | 194,800 (Direct) |
View |
| 2020-05-20 Exercise |
2020-05-21 4:11 pm |
N/A 2021-02-03 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, Chief Technical Officer |
21,387 | $0 | 194,800 (Direct) |
View |
| 2020-04-30 Option Award |
2020-05-01 7:15 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director |
8,829 | $0 | 123,753 (Direct) |
View |
| 2020-04-30 Option Award |
2020-05-01 7:14 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | MATSUI CONNIE Director |
8,829 | $0 | 248,753 (Direct) |
View |
| 2020-04-30 Option Award |
2020-05-01 7:12 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Kelley Kenneth J Director |
8,829 | $0 | 286,382 (Direct) |
View |
| 2020-04-30 Option Award |
2020-05-01 7:12 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Henderson Jeffrey William Director |
8,829 | $0 | 72,107 (Direct) |
View |